Add time:08/30/2019         Source:sciencedirect.com

A series of novel α-sulfonyl γ-(glycinyl-amino)proline peptidomimetic derivatives were designed, synthesized and assayed for their activities against matrix metalloproteinase-2 (MMP-2), aminopeptidase N (APN)/CD13 and HDACs. The results indicated that all the compounds exhibited highly selective inhibition against MMP-2 as compared with APN and HDACs. The antiproliferative activities of some compounds against SKOV3, HL60 and A549 cells were also investigated. Comparing with the control LY52, compound 12u, with excellent activity both in the enzymatic inhibition assay and cell-based assay, could be used as lead compound for the further development of MMP inhibitors.

We also recommend Trading Suppliers and Manufacturers of 2-([(4-METHOXYPHENYL)SULFONYL]AMINO)-2-PHENYLACETIC ACID (cas 117309-46-3). Pls Click Website Link as below: cas 117309-46-3 suppliers